CRKL promotes hepatocarcinoma through enhancing glucose metabolism of cancer cells via activating PI3K/Akt

Journal of Cellular and Molecular Medicine

Frederick T. Greenaway¹  Yuxiang Tian²  Shuqing Liu²  Chunmei Guo³  Xinxin Lv³  Ming‐Zhong Sun³  Chao Gao³  Dongting Zhao³  Lihong Hao⁴ 

[1] Carlson School of Chemistry and Biochemistry, Clark University, Worcester, MA, USA;Department of Biochemistry, College of Basic Medical Sciences, Dalian Medical University, Dalian, China;Department of Biotechnology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China;Department of Histology and Embryology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China;

关键词: CRKL;    glucose metabolism;    hepatocarcinoma;    PI3K/Akt pathway;   

DOI  :  10.1111/jcmm.16303

来源: Wiley

【 授权许可】

CC BY